SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
18775/1/02 conference call notes 1. 1st quarter review expects license revenue to software salesperson-5/1/2002
1876PALO ALTO, Calif., Nov. 26 /PRNewswire/ -- Incyte Genomics, Inc. (Nasdaq: INCY -smh-2/17/2002
1875Ambion Licenses RNA Amplification Patents from Incyte Genomics AUSTIN, Texas annigel bates-2/15/2002
1874Based on the CC..do you feel Incyte is better led by new management? My initialKushi Kullar-2/14/2002
1873and the question was raised, and i'm paraphrasing, if db $ are at an approxsoftware salesperson-2/13/2002
1872The take from Briefing, not good in the revenue shortfall(revenue shortfalls seetom pope-2/13/2002
1871<i>little info</i> Wow, no kidding. Most of it was in the PR. Thannigel bates-2/13/2002
18702/13/02 conference call notes 1. 2002 guidance rev. = 130- 150 m ( database resoftware salesperson-2/13/2002
1869Incyte Reports 2001 Fourth Quarter and Year End Financial Results PALO ALTO, Canigel bates-2/13/2002
1868genomeweb.com <i>NEW YORK, Feb. 6 - Systems biology company Beyond Genomicnigel bates-2/6/2002
1867Thanks for the article tuck, but I find it amazing that the anonymous Genome WebBiotech Jim-1/15/2002
1866Dave, I gather you are aware of this, but for those who were not able to attendtuck-1/15/2002
1865The buzz word's today are facilitation and/or alternative dispute resolutionlnkennedy-12/23/2001
1864Agreed, the companies were calling the shots and agreed to not agree - in the meRocketman-12/23/2001
1863Attorneys advise clients on what is in their best interest. Only the client maklnkennedy-12/22/2001
1862Yeah, great news! I've been hoping and encouraging them to do this for yearRocketman-12/22/2001
1861Excellent news. It's a year or too late, but welcome nonetheless. Biotech inigel bates-12/22/2001
1860some more musings about settlement of litigation -- how much did incy's new Extra Pale-12/21/2001
1859"Affymetrix and Incyte also are investigating possible future commercial agExtra Pale-12/21/2001
1858Rocketman, Great insight (as always). I've seen it time and time again- A jonathan romanowsky-12/21/2001
1857>>LONDON, Dec 19 (Reuters) - Cambridge Antibody Technology Plc announced ttuck-12/19/2001
1856<i>Re: INCY getting acquired. The only way IMO that this can happen is by nigel bates-12/12/2001
1855diaDexus, this is a company that has been a big disappointment to me. Too pharmRocketman-12/6/2001
1854BJ, If INCY is ready to get back into drug development, great, the markets will Rocketman-12/6/2001
1853diaDexus Grants License to Quest Diagnostics for Novel Genomics-Based Colorectalnigel bates-12/6/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News